Showing results (241-250 of 359) with videos related to

Sort By:
Pageof 36
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Primary Central Nervous System Lymphoma Tumor Biopsies Show Heterogeneity in Gene Expression Profiles, Genetic Subtypes, and in vitro Drug Sensitivity to Kinase InhibitorsYuan Xiao Zhu, Jasper Ch Wong, Talal Hilal, et al.
Clinical Chemistry|January 4, 2024
Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation SequencingJennifer M Grants, Christina May, Josh Bridgers, et al.
The Journal of Molecular Diagnostics : JMD|February 13, 2018
Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma ManagementStacy S Hung, Barbara Meissner, Elizabeth A Chavez, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 7, 2017
Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung diseaseShawn T Terryah, Robert C Fellner, Saira Ahmad, et al.
Science Advances|August 1, 2015
The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeabilityCornelia S Hahn, David W Scott, Xin Xu, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomasJie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Bioinformatics (Oxford, England)|June 11, 2026
LCR-modules: a collection of workflows for cancer genome analysisKostiantyn Dreval, Laura K Hilton, Bruno M Grande, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell LymphomaKit I Tong, Sharon Yoon, Keren Isaev, et al.
British Journal of Haematology|August 16, 2023
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cellsElaine Y L Chung, Giulio Sartori, Maurilio Ponzoni, et al.
Cancer Discovery|June 3, 2022
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCLMin Xia, Liron David, Matt Teater, et al.
Pageof 36